Results 201 to 210 of about 123,600 (352)

Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Objective To retrospectively analyze the early efficacy and safety of azacitidine plus lisaftoclax in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome with increased blasts (MDS‐IB), providing a reliable clinical reference.
Shan Meng, Wanhong Zhao, Hui Zhang, Bo Lei, Wanggang Zhang, Yilin Zhang, Jin Wang, Yinxia Chen, Xingmei Cao, Liufang Gu   +9 more
wiley   +1 more source

Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome Patient. [PDF]

EJHaem
Ma L, Shen Y, Chang J, Suo S, Wang L, Zhu W, Qiao J, Tong H.   +7 more
europepmc   +1 more source

MOESM1 of A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

, 2016
Gege Feng, Robert Gale, Wen Cui, Wenyu Cai, Gang Huang, Zefeng Xu, Tiejun Qin, Yue Zhang, Bing Li, Liwei Fang, H Zhang, Li Pan, Naibo Hu, Shiqiang Qu, Wang, Jingya, Yajuan Cui, Zhijian Xiao   +16 more
openalex   +1 more source

Reticulated Platelets and an Optimal Model for Differentiating Thrombocytopenia Etiologies

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Objectives This study aimed to investigate the clinical value of reticulated platelets (RtcPLT) percentage derived from an automated hematology analyzer in differentiating thrombocytopenia due to peripheral etiology from decreased bone marrow production (BME). In addition, a secondary objective was to establish specific reference intervals for
Tung Thanh Tran, Quyen Ngoc Truong, Hong Phuoc Mac, Thang Thanh Phan, Tai Chau Quach, Son Truong Nguyen   +5 more
wiley   +1 more source

Myelodysplastic Syndrome in a Patient With Cronkhite-Canada Syndrome. [PDF]

Clin Case Rep
Shim KG, Khadarian K, Samadder J, Zhou J, Yi CA.   +4 more
europepmc   +1 more source

Early Transplantation After Pretransplant Reduction of TP53‐Altered Clones and Prolonged Dose‐Adjusted Azacitidine Maintenance: A Three‐Case Series

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT TP53‐altered myeloid neoplasms are associated with an extremely high risk of relapse even after allogeneic hematopoietic cell transplantation (allo‐HCT), and the optimal pretransplant and posttransplant strategies remain undefined. We report the cases of three patients with TP53‐altered myeloid neoplasms who achieved durable complete remission
Fuyuki Yamagata, Kyoko Yoshihara, Yasuhito Nannya, Mami Samori, Saki Takahashi, Tomoko Kumamoto, Yoshiyuki Fujita, Nobuto Utsunomiya, Satoshi Yoshihara   +8 more
wiley   +1 more source

Oxidative Stress and DNA Epigenetic Modifications in Cancer: Mechanisms and Targeted Therapeutics

MedComm – Oncology, Volume 5, Issue 2, June 2026.
Reactive oxygen species (ROS) modulate DNA methyltransferases (DNMTs), ten‐eleven translocation family proteins (TETs) and their cofactors, reshaping 5‐methylcytosine (5mC)/5‐hydroxymethylcytosine (5hmC)/5‐formylcytosine (5fC) landscapes and gene expression in cancer cells. In turn, epigenetic control of antioxidant and metabolic pathways feeds back on
Xishan Yang, Qitai Chen, YuJie Yu, Yi Zang, Rujia Zheng, Zhe Zhang, Shuaijun Lu, Li Zhou   +7 more
wiley   +1 more source

Behçet's syndrome-like features revealing myelodysplastic syndrome with <i>TP53</i> mutation: a case report. [PDF]

Front Immunol
Pesic A, Ljubicic J, Todorovic Balint M, Klaassen K, Andjelkovic M, Pavlovic S, Stojanovic M.   +6 more
europepmc   +1 more source

Venovenous Extracorporeal Membrane Oxygenation for Alveolar Hemorrhage During Mitral Valve Repair via Right Minithoracotomy in a Patient With Myelodysplastic Syndrome [PDF]

Motoki Nagatsuka, Tohru Asai, Kenichiro Noguchi, Daisuke Hama, Chishio Arai   +4 more
openalex   +1 more source

Oncofetal Biology: From Fundamental Mechanisms to Emerging Therapeutic Opportunities

MedComm – Oncology, Volume 5, Issue 2, June 2026.
Oncofetal biology provides a transformative framework for understanding cancer initiation, progression, and therapeutic intervention. This review synthesizes the core molecular mechanisms connecting embryonic development and tumorigenesis from a multidisciplinary standpoint and outlines future research trajectories and clinical applications, and we aim
Yang Liu, Kaifeng Niu, Qingran Kong, Shaorong Gao   +3 more
wiley   +1 more source